Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_001287174.1(ABCC8):c.4138C>T (p.Arg1380Cys) | 6833 | ABCC8 | Pathogenic | 137852673 | RCV000009674; RCV000009673; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C1835887,OMIM:610374 | 11 | 17417462 | 17417462 | NM_001287174.1:c.4138C>T | NP_001274103.1:p.Arg1380Cys | NC_000011.9:g.17417462G>A,NC_000011.9:g.17417462G>T | OMIM Allelic Variant:600509.0019 | C0011860 125853 Diabetes mellitus type 2; C1835887 610374 Transient neonatal diabetes mellitus 2 | | |
NM_001287174.1(ABCC8):c.1744C>G (p.Leu582Val) | 6833 | ABCC8 | Pathogenic | 137852674 | RCV000009676; RCV000009675; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C1835887,OMIM:610374 | 11 | 17452434 | 17452434 | NM_001287174.1:c.1744C>G | NP_001274103.1:p.Leu582Val | NC_000011.9:g.17452434G>C | OMIM Allelic Variant:600509.0020 | C0011860 125853 Diabetes mellitus type 2; C1835887 610374 Transient neonatal diabetes mellitus 2 | | |
NM_001626.5(AKT2):c.821G>A (p.Arg274His) | 208 | AKT2 | Pathogenic | 121434593 | RCV000015016; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 19 | 40743886 | 40743886 | NM_001626.5:c.821G>A | NP_001617.1:p.Arg274His | NC_000019.9:g.40743886C>T | OMIM Allelic Variant:164731.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_023083.3(CAPN10):c.471-176G>A | 11132 | CAPN10 | risk factor | 3792267 | RCV000005398; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 2 | 241531174 | 241531174 | NM_023083.3:c.471-176G>A | | NC_000002.11:g.241531174G>A | OMIM Allelic Variant:605286.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_017774.3(CDKAL1):c.371+11426A>C | 54901 | CDKAL1 | Uncertain significance | 10946398 | RCV000001037; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 6 | 20661034 | 20661034 | NM_017774.3:c.371+11426A>C | | NC_000006.11:g.20661034A>C | OMIM Allelic Variant:611259.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_017774.3(CDKAL1):c.371+30101A>G | 54901 | CDKAL1 | Uncertain significance | 7756992 | RCV000001038; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 6 | 20679709 | 20679709 | NM_017774.3:c.371+30101A>G | | NC_000006.11:g.20679709A>G | OMIM Allelic Variant:611259.0002 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_006208.2(ENPP1):c.517A>C (p.Lys173Gln) | 5167 | ENPP1 | Benign;risk factor | 1044498 | RCV000014559; RCV000014558; RCV000033192; RCV000178259; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C0028754,OMIM:601665,ORPHA:71529,SNOMED CT:414916001; MedGen:C1852091; MedGen:CN169374 | 6 | 132172368 | 132172368 | NM_006208.2:c.517A>C | NP_006199.2:p.Lys173Gln | NC_000006.11:g.132172368A>C | OMIM Allelic Variant:173335.0006 | C0011860 125853 Diabetes mellitus type 2; C1852091 Insulin resistance, susceptibility to; CN169374 not specified; C0028754 601665 Obesity | | |
NM_000160.4(GCGR):c.118G>A (p.Gly40Ser) | 2642 | GCGR | Pathogenic | 1801483 | RCV000017542; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 17 | 79767715 | 79767715 | NM_000160.4:c.118G>A | NP_000151.1:p.Gly40Ser | NC_000017.10:g.79767715G>A | OMIM Allelic Variant:138033.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_001083112.2(GPD2):c.1904T>C (p.Phe635Ser) | 2820 | GPD2 | Pathogenic | 121918407 | RCV000017461; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 2 | 157435621 | 157435621 | NM_001083112.2:c.1904T>C | NP_001076581.2:p.Phe635Ser | NC_000002.11:g.157435621T>C | OMIM Allelic Variant:138430.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_000545.6(HNF1A):c.1522G>A (p.Glu508Lys) | 6927 | HNF1A | not provided | 483353044 | RCV000122743; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 12 | 121437091 | 121437091 | NM_000545.6:c.1522G>A | NP_000536.5:p.Glu508Lys | NC_000012.11:g.121437091G>A | - | C0011860 125853 Diabetes mellitus type 2 | | |
NM_000458.3(HNF1B):c.1395C>G (p.Ser465Arg) | 6928 | HNF1B | Pathogenic | 121918673 | RCV000013476; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 17 | 36061127 | 36061127 | NM_000458.3:c.1395C>G | NP_000449.1:p.Ser465Arg | NC_000017.10:g.36061127G>C | OMIM Allelic Variant:189907.0007 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_000457.4(HNF4A):c.1204G>A (p.Val402Ile) | 3172 | HNF4A | Pathogenic | 137853337 | RCV000009793; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 20 | 43057049 | 43057049 | NM_000457.4:c.1204G>A | NP_000448.3:p.Val402Ile | NC_000020.10:g.43057049G>A | OMIM Allelic Variant:600281.0004 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_006548.4(IGF2BP2):c.239+29254C>A | 10644 | IGF2BP2 | risk factor | 4402960 | RCV000002537; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 3 | 185511687 | 185511687 | NM_006548.4:c.239+29254C>A | | NC_000003.11:g.185511687G>T | OMIM Allelic Variant:608289.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_000208.3(INSR):c.3572G>A (p.Arg1191Gln) | 3643 | INSR | Pathogenic | 121913150 | RCV000015815; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 19 | 7120718 | 7120718 | NM_000208.3:c.3572G>A | NP_000199.2:p.Arg1191Gln | NC_000019.9:g.7120718C>T | OMIM Allelic Variant:147670.0021 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_000208.3(INSR):c.3034G>A (p.Val1012Met) | 3643 | INSR | Benign;Pathogenic;Uncertain significance | 1799816 | RCV000015822; RCV000175131; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:CN169374 | 19 | 7125518 | 7125518 | NM_000208.3:c.3034G>A | NP_000199.2:p.Val1012Met | | OMIM Allelic Variant:147670.0029 | C0011860 125853 Diabetes mellitus type 2; CN169374 not specified | | |
NM_005544.2(IRS1):c.1823C>G (p.Thr608Arg) | 3667 | IRS1 | Pathogenic | 104893642 | RCV000022626; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 2 | 227661632 | 227661632 | NM_005544.2:c.1823C>G | NP_005535.1:p.Thr608Arg | NC_000002.11:g.227661632G>C | OMIM Allelic Variant:147545.0003 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_000525.3(KCNJ11):c.67A>G (p.Lys23Glu) | 3767 | KCNJ11 | Benign;drug response;risk factor | 5219 | RCV000009214; RCV000020356; RCV000009215; RCV000146116; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C1833104,OMIM:606176; MedGen:C3152078; MedGen:CN169374 | 11 | 17409572 | 17409572 | NM_000525.3:c.67A>G | NP_000516.3:p.Lys23Glu | NC_000011.9:g.17409572T>C | OMIM Allelic Variant:600937.0014 | C0011860 125853 Diabetes mellitus type 2; C3152078 Exercise stress response, impaired, association with; CN169374 not specified; C1833104 606176 Permanent neonatal diabetes mellitus | | |
NM_005456.3(MAPK8IP1):c.176G>A (p.Ser59Asn) | 9479 | MAPK8IP1 | Pathogenic | 119489103 | RCV000005752; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 11 | 45919710 | 45919710 | NM_005456.3:c.176G>A | NP_005447.1:p.Ser59Asn | NC_000011.9:g.45919710G>A | OMIM Allelic Variant:604641.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_002500.4(NEUROD1):c.332G>T (p.Arg111Leu) | 4760 | NEUROD1 | Pathogenic | 104893649 | RCV000008303; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 2 | 182543256 | 182543256 | NM_002500.4:c.332G>T | NP_002491.2:p.Arg111Leu | NC_000002.11:g.182543256C>A | OMIM Allelic Variant:601724.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_006193.2(PAX4):c.361C>T (p.Arg121Trp) | 5078 | PAX4 | Pathogenic | 114202595 | RCV000014800; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 7 | 127254587 | 127254587 | NM_006193.2:c.361C>T | NP_006184.2:p.Arg121Trp | NC_000007.13:g.127254587G>A | OMIM Allelic Variant:167413.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_000340.1(SLC2A2):c.589G>A (p.Val197Ile) | 6514 | SLC2A2 | Pathogenic | 121909741 | RCV000017470; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 3 | 170724960 | 170724960 | NM_000340.1:c.589G>A | NP_000331.1:p.Val197Ile | NC_000003.11:g.170724960C>T | OMIM Allelic Variant:138160.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_001042.2(SLC2A4):c.1147G>A (p.Val383Ile) | 6517 | SLC2A4 | Uncertain significance | 121434581 | RCV000017469; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 17 | 7189048 | 7189048 | NM_001042.2:c.1147G>A | NP_001033.1:p.Val383Ile | NC_000017.10:g.7189048G>A | OMIM Allelic Variant:138190.0001 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_173851.2(SLC30A8):c.101_107delAAGATCA (p.Lys34Serfs) | 169026 | SLC30A8 | protective | 587777582 | RCV000129931; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 8 | 118159222 | 118159228 | NM_173851.2:c.101_107delAAGATCA | NP_776250.2:p.Lys34Serfs | | OMIM Allelic Variant:611145.0003 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_173851.2(SLC30A8):c.412C>T (p.Arg138Ter) | 169026 | SLC30A8 | protective | 200185429 | RCV000129930; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 8 | 118165323 | 118165323 | NM_173851.2:c.412C>T | NP_776250.2:p.Arg138Ter | NC_000008.10:g.118165323C>T | OMIM Allelic Variant:611145.0002 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_030756.4(TCF7L2):c.382-41435C>T | 6934 | TCF7L2 | drug response | 7903146 | RCV000007838; RCV000211424; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:CN236522 | 10 | 114758349 | 114758349 | NM_030756.4:c.382-41435C>T | | NC_000010.10:g.114758349C>T | OMIM Allelic Variant:602228.0001,PharmGKB Clinical Annotation:1043858905,PharmGKB:1043858905 | C0011860 125853 Diabetes mellitus type 2; CN236522 sulfonamides, urea derivatives response - Efficacy | | |
NM_030756.4(TCF7L2):c.483+7162G>C | 6934 | TCF7L2 | risk factor | 11196205 | RCV000007840; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 10 | 114807047 | 114807047 | NM_030756.4:c.483+7162G>C | | NC_000010.10:g.114807047G>C | OMIM Allelic Variant:602228.0003 | C0011860 125853 Diabetes mellitus type 2 | | |
NM_030756.4(TCF7L2):c.483+9017G>T | 6934 | TCF7L2 | risk factor | 12255372 | RCV000007839; | N | MedGen:C0011860,OMIM:125853,SNOMED CT:44054006 | 10 | 114808902 | 114808902 | NM_030756.4:c.483+9017G>T | | NC_000010.10:g.114808902G>T | OMIM Allelic Variant:602228.0002 | C0011860 125853 Diabetes mellitus type 2 | | |